Please login to the form below

Not currently logged in
Email:
Password:

ReNeuron

This page shows the latest ReNeuron news and features for those working in and with pharma, biotech and healthcare.

ReNeuron aiming to take second stem cell therapy into clinic

ReNeuron aiming to take second stem cell therapy into clinic

UK stem cell specialist ReNeuron has filed for approval to start clinical trials of a treatment for the genetic eye disease retinitis pigmentosa (RP) in the US. ... ReNeuron is already conducting trials of a neural stem cell product called CTX in stroke

Latest news

  • ReNeuron wins orphan status for stem cell therapy ReNeuron wins orphan status for stem cell therapy

    ReNeuron's investigational stem cell therapy has received orphan status in the EU and US for use in a rare eye disorder. ... ReNeuron's CEO Michael Hunt said the company was “delighted” to receive orphan designation for ReN003, adding that it fitted

  • Government funding brings ReNeuron to Wales Government funding brings ReNeuron to Wales

    Stem cell specialist moves from former base in England. Stem cell specialist ReNeuron will shift its operations from England to Wales on the back of an equity investment and funding by ... ReNeuron posted a loss of £6.3m last year and at the end of

  • ReNeuron and Schepens stem cell patent

    ReNeuron Group has signed a patent and know-how license agreement with Schepens Eye Research Institute. ... our collaboration with ReNeuron under this new agreement, bringing us closer to the day when blindness can be treated with stem cells." .

  • Switched on

    Meanwhile, in the UK, ReNeuron is moving forward with testing a stem cell therapy for stroke (ReN001).

  • R&D News in brief

    One of Merlin's investments, ReNeuron, which is developing stem cell-based therapies for people paralysed by a stroke, recently raised money on the stock exchange.

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Glythera appoints Dr Mike Owen Glythera appoints Dr Mike Owen

    Owen is also currently a director of Avacata plc, Blink Biomedical SAS, GammDelta Therapeutics, Ossianix Inc, ReNeuron plc and Zealand Pharma A/S.

  • ReNeuron makes shifts and additions to senior team ReNeuron makes shifts and additions to senior team

    for the development of ReNeuron's in-house manufacturing capability when it relocates its operations to South Wales later this year. ... Their skills and experience will be invaluable as ReNeuron continues its transition into a fully fledged clinical

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    Michael Hunt, who has held the position of CEO since July 2005, will remain on ReNeuron's Board as chief financial officer. ... Bryan Morton, chairman of ReNeuron, commented: “I am delighted to welcome Olav Hellebø to the role of chief executive

  • Simbec appoints ex-ABPI DG as chairman Simbec appoints ex-ABPI DG as chairman

    Earlier this week, ReNeuron stated that the Fund was behind its move from England to Wales, and Sir Chris said that Simbec's appointment of Prof Jones was further evidence for

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the ... Image: Olav Hallebo, CEO, ReNeuron. The global stem cell market is

  • How do you define a biotech company?

    ReNeuron, a leading, clinical-stage stem cell business.

  • Blue Latitude Health

    Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies. ... Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics